# Nebius delivered a massive earnings surprise that crushed skeptics, triggering a short squeeze that pushed the stock up 30%. When famous short-sellers like Michael Burry double down on AI shorts but the underlying companies deliver blowout numbers, it cre

_AI-generated trading idea · BULLISH · NBIS_

> Canonical page: https://commonquant.ai/research/for-you/nebius-delivered-a-massive-earnings-surprise-that-crushed-sk--cec398c0-578a-4cbb-bef9-c877f4ca5067

Nebius delivered a massive earnings surprise that crushed skeptics, triggering a short squeeze that pushed the stock up 30%. When famous short-sellers like Michael Burry double down on AI shorts but the underlying companies deliver blowout numbers, it creates a violent squeeze. Meanwhile, the 16% plunge in rival Cerebras shows investors are ruthlessly dumping weaker AI names to concentrate capital in verified winners. This combination of high short interest and strong fundamental results creates a powerful momentum runway.

## Idea

Nebius delivered a massive earnings surprise that crushed skeptics, triggering a short squeeze that pushed the stock up 30%. When famous short-sellers like Michael Burry double down on AI shorts but the underlying companies deliver blowout numbers, it creates a violent squeeze. Meanwhile, the 16% plunge in rival Cerebras shows investors are ruthlessly dumping weaker AI names to concentrate capital in verified winners. This combination of high short interest and strong fundamental results creates a powerful momentum runway.

## Advanced Analysis

### Verdict: the fundamentals are real, but the trade isn't ready — wait on Nebius

This is a watch-list idea, not a live trade: the entry rules fired zero times across 248 evaluated daily bars in the past 12 months, and the compiled setup could not be backtested at all because the market-data loader failed on the NBIS daily series, so no robust parameter setup was established. The strongest point for the thesis is the fundamental inflection — fiscal 2025 revenue up roughly 479% to $529.8M, a swing from a $641.4M loss to $82.5M of net income, and gross margin recovering to 68.6% — which is exactly the 'verified winner' evidence the idea claims. The strongest point against is free cash flow of negative $3.7B with debt-to-equity up more than five-fold to 89.3%, plus roughly $260M of net insider open-market selling in the most recent 13F cycle (period ended June 30, 2026, not a current reading) — the people closest to the company are selling into strength, not buying the squeeze runway. The stock closed at $226.39, about $10.81 above the 20-day average at $215.58, with the 14-day RSI at 58.9, and the entry logic as compiled asked for the close to be both above and below that same average, which can never be true. I score thesis support at 62 and fundamentals trend at 65, but trade readiness at 20, risk quality at 40, and trigger proximity at 15 — wait for the next ownership filing (showing whether insider selling continued) and the Q1 2026 fundamentals update before acting.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 62/100 |
| Trade readiness | 20/100 |
| Risk quality | 40/100 |
| Trigger proximity | 15/100 |
| Fundamentals trend | 65/100 |
| Score | 40/100 |
| Composite Score | 40/100 |
| Evidence Tier | rules\_not\_triggered |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | rules\_not\_triggered |

### Trade now: NBIS is a watch-list setup, not a live entry

\*\*Do nothing today — but know exactly what you are waiting for.\*\* Nebius (NBIS) closed at $226.39, and the strategy's entry is a pullback-plus-momentum condition, not a chase condition. On the daily chart, the 14-day RSI sits at 58.9, well above the momentum band the entry wants; the stock is also about $10.81 above the 20-day average near $215.58. One of the compiled entry conditions (price above that 20-day average) is currently met, but the RSI half of the band is not, and as written the entry asks for the close to be both above and below the same 20-day average — a condition that cannot be simultaneously true, which is why the research author requested a bounded re-specification rather than treating the empty trigger list as a signal about the thesis. No robust parameter setup has been established yet, so there is no alternate threshold to act on today. \*\*The practical plan:\*\* wait for NBIS to cool back toward the $215.58 area with the 14-day RSI inside a neutral band near 45–50. Until then, 'wait' means concretely: no position, alerts set at $220 (nearest support) and $230.02 (nearest resistance), and a daily check of the 20-day average. If price runs straight through $230 instead, the setup resets — you would then be waiting for the next pullback rather than buying strength. \*\*Risk framing if an entry eventually fires:\*\* the rule set carries a fixed-risk stop of 2.2% per position and a take-profit of 4.5%, roughly a 2-to-1 reward-to-risk, with the nearest support at $220 as the structural line below. That matters because this is a volatile name: the trailing 12 months include a 58.3% maximum drawdown, and sizing should reflect that the 2.2% stop can be hit in a single session. For context, the bull case per the idea's own thesis rests on the blowout 2025 results — revenue up 479% to $529.8M and a swing to $82.5M of net income — but free cash flow of negative $3.7B and debt-to-equity rising to 89.3% mean the momentum has a fundamental fuel question attached. One factual scope note: this strategy could not be backtested as compiled — the market data for NBIS daily bars had two unfilled gaps, so the historical record behind these thresholds is the 248 evaluated recent bars in…

#### NBIS price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | NBIS |
| Timeframe | 1d |

### Scores

- **Conviction score breakdown:** 40
- **Thesis support:** 62
- **Trade readiness:** 20
- **Risk quality:** 40
- **Trigger proximity:** 15
- **Fundamentals trend:** 65

### Watch items

- **NBIS — Price vs 20-day EMA**
- **NBIS — RSI (14)**
- **NBIS — Price vs nearest resistance**
- **NBIS — Price vs nearest support**
- **NBIS — Insider net open-market flow**
- **NBIS — Free cash flow (next XBRL snapshot)**
- **NBIS — Debt-to-equity (next XBRL snapshot)**

## Key details

- Symbols: NBIS
- Timeframes: 1d
- Tags: \#canonical-demand, \#cluster-version:1, \#direction:bullish, \#entity-kind:instrument, \#entity:NBIS, \#horizon:unspecified, \#intent:research, \#symbol:NBIS

## Community

- Upvotes: 0
- Views: 0
- Copies: 0
- Cosigns: 0

## News sources

- [NBIS Stock Surges 30% After Earnings, Defying Michael Burry's Bet Against Nebius](https://finance.yahoo.com/markets/stocks/articles/nbis-stock-surges-30-earnings-193629757.html) — Yahoo Finance
- [Cerebras shares plummet 16% after results fail to impress investors](https://finance.yahoo.com/technology/ai/articles/cerebras-raises-annual-targets-strong-200713556.html) — Yahoo Finance
- [Michael Burry adds to Nvidia and Palantir shorts while loading up on Molina Healthcare, which is down 54% from its high](https://finance.yahoo.com/markets/stocks/articles/michael-burry-adds-nvidia-palantir-184500402.html) — Yahoo Finance

## Related

- [NBIS trade ideas](https://commonquant.ai/stocks/nbis)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (12-month and 5-year, walk-forward tuned) and stress-tested before they can go live, then monitored against the news hourly while they run.